Galaxy Biotech, LLC to Regain Worldwide Rights to HuL2G7, a Clinical Stage Humanized Monoclonal Antibody Against HGF for Treatment of Cancer
6/19/2012 8:05:09 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) And Galaxy Biotech, LLC To Sign Licensing Agreement For HuL2G7, Investigational Agent For Cancer Treatment
7/12/2006 6:49:38 PM
More...
|
Galaxy Biotech, LLC Release: New Targeted Treatment For Brain Tumors Shows Promise In Pre-Clinical Models
2/15/2006 10:51:22 AM
More...
|